D

Devyser Diagnostics AB
F:OL0

Watchlist Manager
Devyser Diagnostics AB
F:OL0
Watchlist
Price: 9.49 EUR -0.73% Market Closed
Market Cap: 153.4m EUR

Operating Margin

-5.3%
Current
Improving
by 27.5%
vs 3-y average of -32.8%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-5.3%
=
Operating Income
kr-12.8m
/
Revenue
kr242.8m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-5.3%
=
Operating Income
€-12.8m
/
Revenue
kr242.8m

Peer Comparison

Country Company Market Cap Operating
Margin
SE
Devyser Diagnostics AB
STO:DVYSR
1.8B SEK
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
381.6B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
185.1B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
160.4B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
118B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.9B USD
Loading...
AU
CSL Ltd
ASX:CSL
86.4B AUD
Loading...
NL
argenx SE
XBRU:ARGX
42.7B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
48.6B USD
Loading...
No Stocks Found

Market Distribution

Lower than 72% of companies in Sweden
Percentile
28th
Based on 2 047 companies
28th percentile
-5.3%
Low
-2 025 693.8% — -1.8%
Typical Range
-1.8% — 12.5%
High
12.5% — 10 459.2%
Distribution Statistics
Sweden
Min -2 025 693.8%
30th Percentile -1.8%
Median 6%
70th Percentile 12.5%
Max 10 459.2%

Devyser Diagnostics AB
Glance View

Market Cap
153.4m EUR
Industry
Biotechnology

Devyser Diagnostics AB engages in the development, manufacture and sale of kits for genetic testing in routine diagnostics. The company is headquartered in Hagersten, Stockholm. The company went IPO on 2021-12-10. The products are used for complex deoxyribonucleic acid (DNA) testing in the areas of hereditary diseases, oncology, and post-transplantation monitoring in order to diagnose genetic diseases and target cancer treatment. The firm has since its inception developed and launched almost 30 products for routine diagnostic use, including Devyser Thrombophilia assay as well as Devyser Resolution XY for analysis of chromosomes X and Y. Devyser Diagnostics’ products are sold directly to the end customer or through hired distributors. The firm provides its products in more than 45 countries.

OL0 Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-5.3%
=
Operating Income
kr-12.8m
/
Revenue
kr242.8m
What is Devyser Diagnostics AB's current Operating Margin?

The current Operating Margin for Devyser Diagnostics AB is -5.3%, which is above its 3-year median of -32.8%.

How has Operating Margin changed over time?

Over the last 3 years, Devyser Diagnostics AB’s Operating Margin has increased from -34.4% to -5.3%. During this period, it reached a low of -48.5% on Mar 31, 2023 and a high of -5.3% on Oct 30, 2025.

Back to Top